Abstract
Case studies of five patients with neuro-myopathic syndromes secondary to bronchogenic carcinoma illustrate the variations of neurologic diseases found in this malignancy. Recognition of this syndrome may be important in the early diagnosis and treatment of bronchogenic carcinoma. The cause of neuromyopathies secondary to bronchogenic carcinoma remains obscure; however, a metabolic abnormality common to all the extrapulmonary manifestations of bronchogenic carcinoma may yet be documented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
